MAPK8 and breast cancer: In parallel, Western blotting results showed that the levels of JNK, p38, ERK remain unchanged while the level of p-JNK, p-p38, p-ERK were upregulated following EM-2 treatment, suggesting that EM-2 activated MAPK signaling pathway to trigger apoptosis in LC and BC cells (Figure 10C).